GOSS Gossamer Bio, Inc. Company Cash Volume

Graphic logo of gossamerbio.com (GOSS)

Gossamer Bio, Inc. (GOSS) is developing a unique therapy system for pulmonary pathologies, positioning itself as a key scientific link. However, long-term profit growth depends on test results and the transition to outsourced manufacturing. The current funding deficit driven by R&D expenses is reflected in the change in cash and cash equivalents, where the indicator remains at 0.05, confirming a stage of planned depletion of existing reserves.

Company Cash on Hand: Gossamer Bio Inc (GOSS) for 07/04/2022 - 11/21/2026

Financial and market metric breakdowns for Gossamer Corp (GOSS)

- stock value and consensus price forecast:
Fundamental valuation:Gossamer Bio, Inc.
Signature product of Gossamer Bio Inc

Minimizing fundamental risks requires an analysis of liquid asset volume, where the value of 0.05 reflects the actual capital reserve available to cover operating expenses without resorting to debt financing. Amidst the revision of the clinical strategy at Gossamer Bio, Inc. (GOSS), this metric determines the survival horizon until a partnership is successful, allowing for an assessment of the probability of a cash crunch through changes in cash on hand.

Competing companies

Company Cash Volume ARGX|BioNTech - Company Cash and Cash Equivalents|Company Cash Volume ABVX (abivax.com)|Company Cash Balance ADMA|Protagonist Therapeutics, Inc. - Company Cash Volume|Company Cash Reserve Immunovant, Inc.|KNSA: Company Cash Volume|GRFS - Company Liquid Assets|ADPT (Adaptive Biotechnologies Inc.) - Company Cash Volume|CLDX: Company Cash Balance|Company Cash Funds Aurinia Pharmaceuticals Inc. (AUPH)|Company Cash Funds BCRX (BioCryst Pharmaceuticals Inc)|Company Cash Volume VERA (Vera Corp)|Company Total Cash Amount DNTH (Dianthus Therapeutics)|PHVS - Company Cash Funds|ABCL: Company Cash Funds|TRML: Company Cash Volume|Company Cash on Hand Precigen, Inc.|Company Cash on Hand PHAR|Nektar Therapeutics - Company Total Cash Volume|Company Cash Funds Upstream Bio Corp (UPB)|Company Cash on Hand Zenas Biopharma ZBIO|Company Cash Funds Immunome Bio IMNM|Company Cash Volume KalVista Pharmaceuticals Inc KALV|SEPN - Company Cash Funds|PVLA - Company Cash Volume|SVRA: Company Cash Volume|RIGL - Company Liquid Assets|ANAB (AnaptysBio Inc) - Company Cash Volume|Company Cash on Hand Astria Corp (ATXS)|Company Cash Volume ENGN|Company Liquid Assets rapt.com|Company Cash Volume JBIO (Aerovate Therapeutics Inc)|Company Liquid Assets Aclaris Therapeutics, Inc. (ACRS)|KYTX - Company Cash Funds|Company Liquid Assets Tiziana Life Sciences TLSA|CABA: Company Cash Volume|Company Cash and Cash Equivalents VTYX|Company Cash on Hand THTX|Company Cash Volume Avalo Therapeutics Inc.|Company Cash Funds Eledon (ELDN)|Company Cash Volume Agenus Inc (AGEN)|Company Cash Volume CLYM (climbbio.com)|ZURA - Company Cash on Hand|atyrpharma.com - Company Cash Volume|ADAG (adagene.com) - Company Cash and Cash Equivalents|IMA (Ikena Oncology) - Company Cash on Hand|Company Cash on Hand Shattuck Labs Inc|EQ (Equillium Inc) - Company Cash Volume|CNTB: Company Cash Balance|Company Cash Volume IMUX|ATRA (Atara Biotherapeutics, Inc.) - Company Cash Balance|Company Cash Volume IFRX (inflarx.de)|X4 Pharmaceuticals - Company Cash Funds|Adicet Bio, Inc. - Company Cash Volume|CELU (celularity.com) - Company Cash and Cash Equivalents|INMB: Company Cash Volume|Barinthus Biotherapeutics PLC (BRNS) - Company Cash Volume|Company Cash Funds Kezar Life Sciences|Company Cash on Hand SAB Biotherapeutics (SABS)|Company Cash Funds Akari Therapeutics Plc (AKTX)|Company Cash on Hand Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Company Cash on Hand|GeoVax Labs (GOVX) - Company Cash Reserve|edesabiotech.com - Company Cash Volume|Company Liquid Assets iBio Corp IBIO|CARM: Company Cash Volume|xtlbio.com (XTLB) - Company Cash Volume|BOLT (Bolt Biotherapeutics) - Company Cash Volume|Company Cash on Hand HCW Biologics (HCWB)|Company Cash on Hand APVO (Aptevo Therapeutics)|AIM - Company Cash Reserve|Aditxt - Company Cash on Hand|Company Cash Position gribio.com|XRTX: Company Cash on Hand|Company Cash Balance HIND (Vyome Holdings)|REVB (Revelation Bio) - Company Cash on Hand|Indaptus Corp (INDP) - Company Cash Volume|Company Cash Funds scinai.com|Company Cash on Hand CalciMedica, Inc. (CALI)|Company Cash Funds Affimed NV (AFMD)|Company Cash Funds ALLK (Allakos Inc)|Company Cash Funds HOOKIPA Pharma, Inc. HOOK|Company Liquid Assets IGM Bio (IGMS)|iTeos Pharma - Company Cash Volume|Company Liquid Assets oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Company Cash Funds|Company Cash and Cash Equivalents THRD